115 related articles for article (PubMed ID: 17003815)
21. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
22. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.
Santoro A; Mancini E; Bolzani R; Boggi R; Cagnoli L; Francioso A; Fusaroli M; Piazza V; Rapanà R; Strippoli GF
Am J Kidney Dis; 2008 Sep; 52(3):507-18. PubMed ID: 18617304
[TBL] [Abstract][Full Text] [Related]
23. Increased plasma adrenomedullin levels in hemodialysis patients with sustained hypotension.
Cases A; Esforzado N; Lario S; Vera M; Lopez-Pedret J; Rivera-Fillat F; Jimenez W
Kidney Int; 2000 Feb; 57(2):664-70. PubMed ID: 10652045
[TBL] [Abstract][Full Text] [Related]
24. Nocturnal hemodialysis increases arterial baroreflex sensitivity and compliance and normalizes blood pressure of hypertensive patients with end-stage renal disease.
Chan CT; Jain V; Picton P; Pierratos A; Floras JS
Kidney Int; 2005 Jul; 68(1):338-44. PubMed ID: 15954925
[TBL] [Abstract][Full Text] [Related]
25. Osmolality and blood pressure stability during hemodialysis.
Singh AT; Mc Causland FR
Semin Dial; 2017 Nov; 30(6):509-517. PubMed ID: 28691402
[TBL] [Abstract][Full Text] [Related]
26. Adrenergic regulation of blood pressure in chronic renal failure.
Lilley JJ; Golden J; Stone RA
J Clin Invest; 1976 May; 57(5):1190-200. PubMed ID: 1262465
[TBL] [Abstract][Full Text] [Related]
27. A randomized, placebo-controlled, phase 2 study of the efficacy and safety of droxidopa in patients with intradialytic hypotension.
Vannorsdall MD; Hariachar S; Hewitt LA
Postgrad Med; 2015 Mar; 127(2):133-43. PubMed ID: 25708022
[TBL] [Abstract][Full Text] [Related]
28. [Arterial hypertension in patients on chronic hemodialysis].
Zogović J; Mladenović Lj
Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
[TBL] [Abstract][Full Text] [Related]
29. Effect of intracarotid administration of morphine and naloxone on plasma vasopressin levels and blood pressure in the dog.
Rockhold RW; Crofton JT; Wang BC; Share L
J Pharmacol Exp Ther; 1983 Feb; 224(2):386-90. PubMed ID: 6822963
[TBL] [Abstract][Full Text] [Related]
30. Relationship between volume status and blood pressure during chronic hemodialysis.
Leypoldt JK; Cheung AK; Delmez JA; Gassman JJ; Levin NW; Lewis JA; Lewis JL; Rocco MV
Kidney Int; 2002 Jan; 61(1):266-75. PubMed ID: 11786109
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular effects of centrally administered arachidonic acid in haemorrhage-induced hypotensive rats: investigation of a peripheral mechanism.
Yalcin M; Aydin C
Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):447-53. PubMed ID: 19702598
[TBL] [Abstract][Full Text] [Related]
32. Hemodialysis in hypotensive heart failure using midodrine.
Bergman SM
Am J Med Sci; 2009 Dec; 338(6):470-3. PubMed ID: 19875951
[TBL] [Abstract][Full Text] [Related]
33. Blood pressure in acute and chronic vasopressin excess: studies of malignant hypertension and the syndrome of inappropriate antidiuretic hormone secretion.
Padfield PL; Brown JJ; Lever AF; Morton JJ; Robertson JI
N Engl J Med; 1981 Apr; 304(18):1067-70. PubMed ID: 7207565
[TBL] [Abstract][Full Text] [Related]
34. Correlation between intradialytic hypotension in patients undergoing routine hemodialysis and use of acetate compared in bicarbonate dialysate.
Thaha M; Yogiantoro M; Soewanto ; Pranawa
Acta Med Indones; 2005; 37(3):145-8. PubMed ID: 16138418
[TBL] [Abstract][Full Text] [Related]
35. Acetylcysteine reduces plasma homocysteine concentration and improves pulse pressure and endothelial function in patients with end-stage renal failure.
Scholze A; Rinder C; Beige J; Riezler R; Zidek W; Tepel M
Circulation; 2004 Jan; 109(3):369-74. PubMed ID: 14732754
[TBL] [Abstract][Full Text] [Related]
36. [Effects of midodrine on symptomatic hypotension during hemodialysis].
Cotera A; Alvo M; Sanhueza ME; Elgueta L; Gormaz JP; Ibáñez C; Cuadra C
Rev Med Chil; 2002 Sep; 130(9):1009-13. PubMed ID: 12434648
[TBL] [Abstract][Full Text] [Related]
37. Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donors.
Chen JM; Cullinane S; Spanier TB; Artrip JH; John R; Edwards NM; Oz MC; Landry DW
Circulation; 1999 Nov; 100(19 Suppl):II244-6. PubMed ID: 10567311
[TBL] [Abstract][Full Text] [Related]
38. Immunoreactive parathyroid hormone after volume change in normo- and hypotensive hemodialysis patients.
Heintz B; Mann H; Kierdorf H; Königs F; Nelson K; Kirsten R; Heicke N; Wieland D; Gladziwa U; Sieberth HG
Clin Nephrol; 1992 Mar; 37(3):140-4. PubMed ID: 1563118
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular effects of centrally injected melittin in hemorrhaged hypotensive rats: the investigation of peripheral mechanisms.
Yalcin M; Savci V
Neuropeptides; 2007 Dec; 41(6):465-75. PubMed ID: 17897713
[TBL] [Abstract][Full Text] [Related]
40. Blood volume controlled hemodialysis in hypotension-prone patients: a randomized, multicenter controlled trial.
Santoro A; Mancini E; Basile C; Amoroso L; Di Giulio S; Usberti M; Colasanti G; Verzetti G; Rocco A; Imbasciati E; Panzetta G; Bolzani R; Grandi F; Polacchini M
Kidney Int; 2002 Sep; 62(3):1034-45. PubMed ID: 12164888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
